Overview

Molecular generation studies how to create new chemical structures or 3D conformations that meet goals such as binding a protein, having useful properties, or matching spectral evidence. Common approaches include autoregressive chemical language models, graph and 3D diffusion or flow-matching models, and fragment-based generators; reinforcement learning, search, and active learning can steer their outputs toward desired properties. Researchers compare methods on benchmarks such as QM9, ZINC, MOSES, CrossDocked, and MassSpecGym, evaluating validity, novelty, diversity, property performance, and structural fit. A central challenge is balancing goal-directed optimization with chemical plausibility, diversity, and synthesizability, while ensuring that gains on computational proxies hold up in independent or experimental tests.

Latest papers

253 papers16 papers in the last four weeks, down 52% on the four weeks before. 0.1% of all new papers.

Oct 3, 2025

SPID: Distilled Protein Backbone Generation

Diffusion- and flow-based generative models have recently demonstrated strong performance in protein backbone generation tasks, offering unprecedented capabilities for de novo protein design. However, despite their generation quality, these models are constrained by slow sampling, often requiring hundreds of iterative steps. This computational bottleneck limits their practical utility in large-scale protein discovery, where thousands to millions of candidate structures are needed. To address this challenge, we explore the techniques of score distillation, which has shown great success in reducing the number of sampling steps in the vision domain while maintaining high generation quality. However, a straightforward adaptation of these methods results in unacceptably low designability. We introduce Score Protein identity Distillation (SPID), which resolves this incompatibility by combining few-step generation with inference-time noise scaling. SPID adapts the Score identity Distillation (SiD) framework to both diffusion- and flow-based models without requiring access to pretraining data. Applied to the Proteina flow-matching model, our 16-step generator achieves 94.4% designability, matching the 400-step teacher, while delivering more than a 20-fold reduction in effective backbone-generation time and maintaining comparable diversity and novelty. SPID generalizes across unconditional generation, fold-class conditional generation, and motif scaffolding, and extends to equivariant diffusion architectures, achieving significant reduction in generation time with comparable generation quality to the teacher in all tasks. The resulting reduction in inference cost could facilitate large-scale in silico protein design, thereby advancing diffusion-based models toward real-world protein engineering applications. The PyTorch implementation is available at https://github.com/LY-Xie/SiD_Protein
Aug 31, 2025

Why Pool When You Can Flow? Active Learning with GFlowNets

The scalability of pool-based active learning is limited by the computational cost of evaluating large unlabeled datasets, a challenge that is particularly acute in virtual screening for drug discovery. While active learning strategies such as Bayesian Active Learning by Disagreement (BALD) prioritize informative samples, it remains computationally intensive when scaled to libraries containing billions samples. In this work, we introduce BALD-GFlowNet, a generative active learning framework that circumvents this issue. Our method leverages Generative Flow Networks (GFlowNets) to directly sample objects in proportion to the BALD reward. By replacing traditional pool-based acquisition with generative sampling, BALD-GFlowNet achieves scalability that is independent of the size of the unlabeled pool. In our virtual screening experiment, we show that BALD-GFlowNet achieves a performance comparable to that of standard BALD baseline while generating more structurally diverse molecules, offering a promising direction for efficient and scalable molecular discovery.
Aug 20, 2025

Cross-Modality Controlled Molecule Generation with Diffusion Language Model

The increasing variety of molecular data creates a need for generative models that can flexibly incorporate heterogeneous constraints across modalities. However, existing SMILES-based diffusion models are typically designed for a fixed conditioning modality, and introducing new constraints often requires retraining the model. To address this limitation, we propose Cross-Modality Controlled Molecule Generation with Diffusion Language Model (CMCM-DLM), a modular framework that extends a pre-trained diffusion model to support heterogeneous molecular constraints without retraining the backbone. We demonstrate CMCM-DLM using two complementary modalities: molecular structure and chemical properties. Specifically, a Structure Control Module (SCM) guides early diffusion steps to establish the molecular scaffold, while a Property Control Module (PCM) subsequently steers generation toward target chemical properties. This staged design enables flexible integration of different molecular constraints within a unified generative framework. Experiments on multiple datasets demonstrate effective cross-modal controllability and strong adaptability, highlighting the potential of CMCM-DLM for heterogeneous molecular data modeling and data-driven drug discovery.
Aug 19, 2025

A Large Scale Investigation of Scaling Limits in Chemical Language Models

Chemical Language Models (CLMs) are increasingly used in de novo drug design, driven by recent growth in model scale, compute, and dataset size. However, the relationship between design choices, training dynamics, and downstream generation quality remains poorly understood. We present a compute-controlled scaling study of CLMs comprising more than 30,000 experiments across molecular representations (SMILES, SELFIES, SAFE), tokenizations (atom-level and byte-pair encoding), model scales (0.5M-1B parameters), leakage-controlled datasets (MOSES, ChEMBL, PubChem, ZINC-22), and architectures (decoder-only and encoder-decoder). By fitting IsoFLOP profiles, we establish clear scaling trends in pretraining loss, but find that these improvements do not translate into comparable gains in goal-directed molecular design. Layer-wise probing and sparse autoencoder analysis reveal continued development of chemical representations: chemical syntax saturates early, while semantic properties emerge more slowly and become increasingly accessible with further training and model scale. These representational gains coexist with diminishing improvements in goal-directed generation under the evaluated protocols and oracle budgets. Our resulting suite of models, NovoMolGen, achieves state-of-the-art results, outperforming prior CLMs and specialized generative models in goal-directed molecular generation across drug discovery tasks. These findings expose a disconnect between chemical representation learning and downstream molecular design, motivating the development of pretraining paradigms that more directly learn chemical semantics.
Jul 27, 2025

Generative molecule evolution using 3D pharmacophore for efficient Structure-Based Drug Design

Recent breakthroughs in generative models have shown great promise for drug discovery, yet Structure-Based Drug Design (SBDD) faces two critical challenges: the scarcity of high-quality protein-ligand complex data and the practical synthesizability of generated molecules. While ligand-based approaches benefit from billion-scale small molecule datasets, they often lack the structural context of the target protein. To address these dual challenges of data scarcity and synthetic inaccessibility, we propose MEVO, a generative molecular evolutionary framework that operates within a synthesizable chemical space. MEVO introduces a reaction-aware generative model trained on reaction routes constructed by applying predefined reaction templates to Enamine Building Blocks. The model jointly generates molecules and corresponding synthesis sketches consistent with these templates. By integrating this generative capability into a pocket-aware evolutionary strategy, MEVO iteratively refines molecular structures within the synthesizable chemical space, guided by a hierarchical scoring function that combines fast approximation with rigorous Absolute Binding Free Energy Perturbation (ABFEP) calculations. This framework efficiently generates high-affinity, synthetically feasible binders for diverse protein targets. We validate MEVO's performance through rigorous ABFEP calculations, demonstrating its ability to design potent inhibitors for challenging targets such as KRASG12D^{\textrm{G12D}}, achieving affinities comparable to known active inhibitors. By integrating the data richness of ligand-based learning with the precision of structure-based optimization, MEVO offers a holistic solution that ensures both high binding affinity and synthetic accessibility, paving the way for more efficient and practical structure-based drug design.
Jun 9, 2025

ProteinZero: Self-Improving Protein Generation via Online Reinforcement Learning

Protein generative models have shown remarkable promise in protein design, yet their success rates remain constrained by reliance on curated sequence-structure datasets and by misalignment between supervised objectives and real design goals. We present ProteinZero, an online reinforcement learning framework for inverse folding models that enables scalable, automated, and continuous self-improvement with computationally efficient feedback. ProteinZero employs a reward pipeline that combines structural guidance from ESMFold with a novel self-derived ddG predictor, providing stable multi-objective signals while avoiding the prohibitive cost of physics-based methods. To ensure robustness in online RL, we further introduce a novel embedding-level diversity regularizer that mitigates mode collapse and promotes sequence-level diversity among generated designs. Within a general RL formulation balancing multi-reward optimization, KL-divergence from a reference model, and diversity regularization, ProteinZero achieves robust improvements across designability, predicted stability, recovery, and diversity. On the CATH-4.3 benchmark, it consistently outperforms state-of-the-art baselines including ProteinMPNN, ESM-IF, and InstructPLM, reducing design failure rates by 36-48% and achieving success rates above 90% across diverse folds. Importantly, a complete RL run can be executed on a single 8xGPU node within three days, including reward computation and data generation. These results indicate that efficient online RL fine-tuning can complement supervised pretraining by allowing protein generative models to evolve continuously from their own outputs and optimize multiple design objectives without labeled data, opening new possibilities for exploring the vast protein design space. Code and model checkpoints are available at https://github.com/ziwenwang28/ProteinZero.
May 25, 2025

PDFBench: A Benchmark for De novo Protein Design from Function

Function-guided protein design is a crucial task with significant applications in drug discovery and enzyme engineering. However, the field lacks a unified and comprehensive evaluation framework. Current models are assessed using inconsistent and limited subsets of metrics, which prevents fair comparison and a clear understanding of the relationships between different evaluation criteria. To address this gap, we introduce PDFBench, the first comprehensive benchmark for function-guided denovo protein design. Our benchmark systematically evaluates eight state-of-the-art models on 16 metrics across two key settings: description-guided design, for which we repurpose the Mol-Instructions dataset, originally lacking quantitative benchmarking, and keyword-guided design, for which we introduce a new test set, SwissTest, created with a strict datetime cutoff to ensure data integrity. By benchmarking across a wide array of metrics and analyzing their correlations, PDFBench enables more reliable model comparisons and provides key insights to guide future research.
May 23, 2025

A Comprehensive Benchmark of Computational Models for Antibody--Antigen Binding Affinity

Computational antibody design requires benchmarks that measure functional binding rather than similarity to natural sequences. Here we present AbBiBench, which treats the antibody--antigen complex as the evaluation unit and harmonizes 216,560 experimental measurements spanning 13 antibodies and 9 antigens. We compare 20 computational approaches without task-specific training or fine-tuning. The analyses show that global structure-conditioned inverse folding yields the strongest and most consistent affinity rankings, whereas antibody-specific fine-tuning does not consistently improve performance. Across models, rankings are more useful for prioritizing likely affinity gains than for excluding weak variants. In a subsequent case study, multi-objective evaluation of model-generated F045-092 CDR-H3 variants for H1N1 binding revealed a trade-off between predicted binding potential and evolutionary sequence plausibility; all 21 selected candidates produced H1-reactive ELISA signals. AbBiBench provides an open framework for developing and evaluating function-aware antibody design methods.
May 18, 2025

AbFlowNet: Optimizing Antibody-Antigen Binding Energy via Diffusion-GFlowNet Fusion

Complementarity Determining Regions (CDRs) are critical segments of an antibody that facilitate binding to specific antigens. Current computational methods for CDR design utilize reconstruction losses and do not jointly optimize binding energy, a crucial metric for antibody efficacy. Rather, binding energy optimization is done through computationally expensive Online Reinforcement Learning (RL) pipelines rely heavily on unreliable binding energy estimators. In this paper, we propose AbFlowNet, a novel generative framework that integrates GFlowNet with Diffusion models. By framing each diffusion step as a state in the GFlowNet framework, AbFlowNet jointly optimizes standard diffusion losses and binding energy by directly incorporating energy signals into the training process, thereby unifying diffusion and reward optimization in a single procedure. Experimental results show that AbFlowNet outperforms the base diffusion model by 3.06% in amino acid recovery, 20.40% in geometric reconstruction (RMSD), and 3.60% in binding energy improvement ratio. ABFlowNet also decreases Top-1 total energy and binding energy errors by 24.8% and 38.1% without pseudo-labeling the test dataset or using computationally expensive online RL regimes.
Apr 24, 2025

OmegAMP: Targeted AMP Discovery via Biologically Informed Generation

Deep learning-based antimicrobial peptide (AMP) discovery faces critical challenges such as limited controllability, lack of representations that efficiently model antimicrobial properties, and low experimental hit rates. To address these challenges, we introduce OmegAMP, a framework designed for reliable AMP generation with increased controllability. Its diffusion-based generative model leverages a novel conditioning mechanism to achieve fine-grained control over desired physicochemical properties and to direct generation towards specific activity profiles, including species-specific effectiveness. This is further enhanced by a biologically informed encoding space that significantly improves overall generative performance. Complementing these generative capabilities, OmegAMP leverages a novel synthetic data augmentation strategy to train classifiers for AMP filtering, drastically reducing false positive rates and thereby increasing the likelihood of experimental success. Our in silico experiments demonstrate that OmegAMP delivers state-of-the-art performance across key stages of the AMP discovery pipeline, enabling us to achieve an unprecedented success rate in wet lab experiments. We tested 25 candidate peptides, 24 of them (96%) demonstrated antimicrobial activity, proving effective even against multi-drug resistant strains. Our findings underscore OmegAMP's potential to significantly advance computational frameworks in the fight against antimicrobial resistance.
Jan 3, 2025

Active Learning Enables Generation of Molecules that Advance the Known Pareto Front

Although generative models hold promise for discovering molecules with optimized desired properties, they often fail to suggest synthesizable molecules that improve upon the properties of the structures represented in the training distribution. We find that this limitation arises not only from the molecule generation process itself, but also from the poor generalization capabilities of molecular property predictors. We address this challenge by creating a closed-loop molecule generation pipeline with iterative retraining on new quantum chemical simulation data. Compared against static, single-pass generative modeling approaches, only our closed-loop iterative workflow generates molecules with properties extending beyond the training distribution (up to 0.44 standard deviations beyond the original range) and achieves a 79% improvement in out-of-distribution molecule classification accuracy. Furthermore, by conditioning molecular generation on thermodynamic stability data obtained during the iterative loop, the proportion of stable and hence potentially synthesizable molecules generated is 3.5x higher than the next-best model.
Nov 10, 2024

MolMiner: Toward Controllable, 3D-Aware, Fragment-Based Molecular Design

We introduce MolMiner, a fragment-based, geometry-aware, and order-agnostic autoregressive model for molecular design. MolMiner supports high-dimensional conditional control over twelve physicochemical and structural properties from partial specifications, constructs molecules via symmetry-aware fragment attachments, and conditions each generation step on force-field-relaxed three-dimensional geometry of the partial structure. Conditional control emerges without auxiliary property losses. On targeted property windows, conditioning lifts hit rates by up to 5.25x over unconditional generation and 3.5x over the training distribution itself -- overriding the model's intrinsic biases -- at the cost of a small reduction in unconditional distributional fidelity. MolMiner unifies dynamic geometry, symmetry handling, order-agnostic generation, and scalable multi-property conditioning within a single framework.
Jul 26, 2024

Small Molecule Optimization with Large Language Models

Molecular optimization, the process of designing molecules with desirable properties, represents a critical challenge in drug discovery. The recent advancements in large language models (LLMs) have opened new opportunities for their integration with traditional molecular optimization algorithms to improve performance. In this work, we propose Molecular Language Model powered Evolutionary Algorithm (Mol-E), an evolutionary algorithm that relies on the generative capabilities of LLMs trained on molecules and molecular properties. Scientific Contribution. Mol-E obtains the highest aggregate Top-10 AUC among the comparable full-23-task results considered here, scoring 17.500 in the task-agnostic regime, in which the oracle is treated strictly as a black box, and 20.551 in the task-informed regime, in which the optimizer receives a fixed semantic description of the objective. Mol-E also improves over the evaluated baselines on multi-property optimization with docking against DRD2, MK2, and AChE.